{
    "nctId": "NCT01231022",
    "briefTitle": "Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)",
    "officialTitle": "Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Neoplasm Metastasis",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "Protective effection of peripheral hematopoietic stem cell infusion for DILI",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients should be histologically confirmed with metastatic breast cancer;\n* an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2;\n* Normal cardiac, hepatic, renal and bone marrow functions;\n* Life expectancy \u22653 months;\n\nExclusion Criteria:\n\n* previous history of other malignancies;\n* Central nervous system metastases;\n* Serious or uncontrolled concurrent medical illness.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}